Bioscience Animal Health Public Company LimitedSET: BIS🇹🇭 TH

News & Press Releases

SET Announcements

13 Nov 2026

Exercise of Shareholders' Rights to Propose Agenda for the 2027 Annual General Meeting of Shareholders and Nominate a person to be elected as a director of the Company in advance

Read the full announcement on the SET website ↗
10 Nov 2026

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2026

Read the full announcement on the SET website ↗
10 Nov 2026

Financial Performance Quarter 3 (F45) (Reviewed)

Read the full announcement on the SET website ↗
10 Nov 2026

Financial Statement Quarter 3/2026 (Reviewed)

Read the full announcement on the SET website ↗
10 Nov 2026

Notification on Receipt of the Report on the Result of the Securities Acquisition of Bioscience Animal Health Public Company Limited (Form 256-2)

Read the full announcement on the SET website ↗
30 Oct 2026

Amendment to the Opinion of Bioscience Animal Health Public Company Limited on the Tender Offer for Securities (Form 250-2) and Opinion of the Independent Financial Advisor (Revised No.2)

Read the full announcement on the SET website ↗
28 Oct 2026

Notification on Receipt of the Report on the Preliminary Result of the Tender Offer for Securities of Bioscience Animal Health Public Company Limited (Form 247-6-Khor)

Read the full announcement on the SET website ↗
27 Oct 2026

Amendment to the Opinion of Bioscience Animal Health Public Company Limited on the Tender Offer for Securities (Form 250-2) and Opinion of the Independent Financial Advisor (Revised No.1)

Read the full announcement on the SET website ↗
26 Oct 2026

Notification on Receipt of the Amendment to the Tender Offer (Form 247-4) (Revised No.2)

Read the full announcement on the SET website ↗
14 Oct 2026

Submission of Bioscience Animal Health Public Company Limited's Opinion on the Tender Offer (Form 250-2) and the Independent Financial Advisor's Opinion

Bioscience Animal Health Public Company Limited (BIS) has submitted its opinion on the tender offer (Form 250-2) and the independent financial advisor's opinion. The offerors are Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya, and Mrs. Rungnapa Techasattaya at a net price of 1.2666 baht per share. The tender offer period runs from 25-Sep-2026 to 03-Nov-2026, with payment settlement on 05-Nov-2026.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
8 Oct 2026

Notification on Receipt of the Amendment to the Tender Offer (Form 247-4) (Revised No.1)

The offerors, Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya and Mrs. Rungnapa Tachasattaya, reported the amendment to the tender offer for Bioscience Animal Health Public Company Limited (BIS). The tender offer period is from 25-Sep-2026 to 03-Nov-2026 at an offer price of 1.27 baht per share, with a net price of 1.2666 baht per share. The tender is not for delisting, and the securities payment settlement will occur on 05-Nov-2026.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
22 Sept 2026

Notification on the Receipt of Tender Offer for the Securities (Form 247-4)

Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya and Mrs. Rungnapa Tachasattaya have submitted a tender offer for shares of Bioscience Animal Health Public Company Limited (BIS) at 1.27 baht per share (net price 1.2666 baht per share). The tender offer period runs from 25-Sep-2026 to 03-Nov-2026, with payment settlement on 05-Nov-2026. The offer is for cash and is not for delisting. Globlex Securities Company Limited is the tender offer agent.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
11 Sept 2026

Notification of the Board of Directors' Resolutions Regarding the Receipt of Form 247-3, the Appointment of an IFA to Provide an Opinion on the Tender Offer and the appointment of a director to replace a director who has vacated

Bioscience Animal Health Public Company Limited (BIS) received a tender offer from Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya, and Mrs. Rungnapa Tachasattaya at a cash offer price of 1.27 baht per share and a net price of 1.2666 baht per share. The tender offer is not for delisting, and Globlex Securities Company Limited is the tender offer agent. Separately, Mr. Seksom Attamangkune was appointed as a director of BIS, effective September 11, 2026.

Summarised automatically from the announcement filed with SET.

Read the full announcement on the SET website ↗
11 Sept 2026

Clarification on the Trading of the Company's Shares and Change in Shareholding Structure (Update)

Read the full announcement on the SET website ↗
10 Sept 2026

Clarification on the Trading of the Company's Shares and Change in Shareholding Structure

Read the full announcement on the SET website ↗
11 Aug 2026

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2026

Read the full announcement on the SET website ↗
11 Aug 2026

Financial Performance Quarter 2 (F45) (Reviewed)

Read the full announcement on the SET website ↗
11 Aug 2026

Financial Statement Quarter 2/2026 (Reviewed)

Read the full announcement on the SET website ↗
11 Aug 2026

Interim dividend payment and Special Dividend

Read the full announcement on the SET website ↗
24 Jul 2026

Report on the utilization of the increased capital from the Initial Public Offering (IPO)

Read the full announcement on the SET website ↗
13 May 2026

Financial Performance Quarter 1 (F45) (Reviewed) (Revised)

Read the full announcement on the SET website ↗
12 May 2026

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026

Read the full announcement on the SET website ↗
12 May 2026

Financial Performance Quarter 1 (F45) (Reviewed)

Read the full announcement on the SET website ↗
12 May 2026

Financial Statement Quarter 1/2026 (Reviewed)

Read the full announcement on the SET website ↗
5 May 2026

Publication of the Minutes of the 2026 Annual General Meeting of Shareholders on the Company's website

Read the full announcement on the SET website ↗
22 Apr 2026

Shareholders meeting's resolution

Read the full announcement on the SET website ↗
25 Mar 2026

Dissemination of the Notice of the 2026 Annual General Meeting of Shareholders on the Company's website and submitting questions in advance

Read the full announcement on the SET website ↗
25 Feb 2026

Management Discussion and Analysis Yearly Ending 31 Dec 2025

Read the full announcement on the SET website ↗
25 Feb 2026

Financial Performance Yearly (F45) (Audited)

Read the full announcement on the SET website ↗
25 Feb 2026

Financial Statement Yearly 2025 (Audited)

Read the full announcement on the SET website ↗
25 Feb 2026

Notification of the resolutions of the Board of Directors 1/2026, schedule of the 2026 Annual General Meeting of Shareholders and Dividend payment for the year 2025 performance

Read the full announcement on the SET website ↗
23 Jan 2026

Report on the utilization of the increased capital from the Initial Public Offering (IPO)

Read the full announcement on the SET website ↗
17 Dec 2025

Notification of the resignation of the Chief Executive Officer (CEO) and appointing a new Chief Executive Officer (CEO)

Read the full announcement on the SET website ↗
14 Nov 2025

Exercise of Shareholders' Rights to Propose Agenda for the 2026 Annual General Meeting of Shareholders and Nominate a person to be elected as a director of the Company in advance

Read the full announcement on the SET website ↗
13 Nov 2025

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025

Read the full announcement on the SET website ↗
13 Nov 2025

Financial Performance Quarter 3 (F45) (Reviewed)

Read the full announcement on the SET website ↗
13 Nov 2025

Financial Statement Quarter 3/2025 (Reviewed)

Read the full announcement on the SET website ↗
10 Nov 2025

Company's Holidays 2026

Read the full announcement on the SET website ↗